G0565 Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 365 day implantable sensor, including system activation

Short descriptor: Rem/ins glu snsr 365 dif sit

⚠ Terminated HCPCS Level II 2026
Terminated Code
G0565 was terminated as of 2025-03-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open G0565 in the app →

Look up G0565 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

G0565 is the HCPCS Level II code for Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 365 day implantable sensor, including system activation (2026). It belongs to Section G — Procedures / Professional Services (Temporary). Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Priced by carriers (physician fee schedule).

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Priced by carriers (physician fee schedule) (indicator 13)
Type of Service
Surgery
Effective Date
2025-04-01
Termination Date
2025-03-31
2026 Maintenance
No change this year

References

Cite This Page

Reference G0565 with the canonical source and edition:

G0565 — Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 365 day implantable sensor, including system activation. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/G0565

Canonical URL: https://icd10codingpro.com/hcpcs-codes/G0565

Related Codes in Section G

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial